Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ovid Therapeutics Inc.

1.45
-0.0400-2.68%
Post-market: 1.450.00000.00%19:22 EDT
Volume:1.14M
Turnover:1.67M
Market Cap:103.11M
PE:-2.71
High:1.53
Open:1.53
Low:1.44
Close:1.49
52wk High:2.01
52wk Low:0.2425
Shares:71.11M
Float Shares:59.52M
Volume Ratio:0.74
T/O Rate:1.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5359
EPS(LYR):-0.3663
ROE:-52.77%
ROA:-26.71%
PB:1.85
PE(LYR):-3.96

Loading ...

Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 17, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 07, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Dec 24, 2019

Major Issues Report

Current report, item 5.02
Nov 27, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Nov 22, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 22, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 08, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 01, 2019

Major Issues Report

Current report, items 5.01, 8.01, and 9.01
Oct 08, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Oct 07, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Sep 24, 2019

Major Issues Report

Current report, items 5.03 and 9.01
Sep 23, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Sep 19, 2019

Major Issues Report

Current report, items 3.02, 5.03, 5.07, and 9.01
Sep 12, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Sep 09, 2019

Major Issues Report

Current report, items 8.01 and 9.01